Prevention of Skin Allograft Rejection

Skin allografts remain indispensable in the management of extensive burns, chronic wounds, and certain reconstructive procedures. However, the immunogenic nature of skin, rich in antigen-presenting cells and vascularization, renders it particularly susceptible to acute and chronic rejection. Preventing skin allograft rejection requires a multifaceted approach that integrates immune modulation, histocompatibility matching, and graft monitoring. Immunopathogenesis

Prevention of Skeletal Related Events in Multiple Myeloma

Skeletal-related events (SREs) in multiple myeloma (MM) represent a major cause of morbidity and impaired quality of life. These events, including pathologic fractures, spinal cord compression, need for radiation or surgery to bone, and hypercalcemia, arise from osteolytic bone lesions caused by myeloma-induced bone destruction. Our goal in managing MM is not only to control

Prevention of Seizures Following Cranial Trauma or Surgery

Seizures following cranial trauma or neurosurgical interventions represent a serious neurological complication with implications for recovery, long-term outcomes, and patient safety. These seizures can be classified as: Prevention and management demand a structured approach integrating clinical assessment, pharmacologic prophylaxis, and individualized risk stratification. Risk Factors for Seizures After Cranial Trauma or Neurosurgery Understanding who is

Prevention of Rubella After Exposure

Rubella, also known as German measles, is a contagious viral infection caused by the rubella virus, primarily transmitted via respiratory droplets. Although typically mild in children and adults, rubella poses a significant threat during pregnancy, particularly in the first trimester, due to its association with congenital rubella syndrome (CRS). CRS can lead to serious fetal

Prevention of Rhesus Isoimmunization Affecting Pregnancy

Rhesus isoimmunization, or Rh sensitization, occurs when an Rh-negative mother is exposed to Rh-positive fetal red blood cells (RBCs), triggering an immune response that results in the production of anti-D antibodies. These antibodies can cross the placenta in subsequent pregnancies, leading to hemolytic disease of the fetus and newborn (HDFN)—a severe and sometimes fatal condition.

Prevention of Rh Isoimmunization After First-Trimester Pregnancy

Rh isoimmunization, or Rh sensitization, occurs when an Rh-negative woman is exposed to Rh-positive fetal red blood cells (RBCs), leading to the production of anti-D antibodies. In future pregnancies, these antibodies may cross the placenta and attack Rh-positive fetal cells, resulting in hemolytic disease of the fetus and newborn (HDFN). Even minimal fetomaternal hemorrhage during

Prevention of Rh Isoimmunization After Blood Transfusion

Rh isoimmunization, or Rh alloimmunization, is a potentially serious immunologic reaction that occurs when an Rh-negative individual is exposed to Rh-positive red blood cells (RBCs), typically via blood transfusion. This exposure prompts the immune system to develop anti-D antibodies, leading to complications such as hemolytic transfusion reactions and future incompatibility in transfusion or pregnancy scenarios.

Prevention of Rh Incompatibility Reaction in Pregnancy

Rh incompatibility occurs when an Rh-negative mother carries an Rh-positive fetus, leading to the maternal immune system recognizing fetal red blood cells as foreign and producing antibodies. This sensitization can result in hemolytic disease of the fetus and newborn (HDFN), a serious condition that may cause anemia, jaundice, or even fetal death if not managed

Prevention of Respiratory Distress Syndrome in the Newborn

Respiratory Distress Syndrome (RDS) in newborns is a critical condition primarily caused by insufficient production of pulmonary surfactant, most commonly affecting preterm infants. Surfactant is essential for reducing surface tension in the alveoli, preventing collapse during expiration. Without timely intervention, RDS can lead to significant morbidity and mortality. Preventive strategies must be initiated during the

Prevention of Relapse to Opioid Dependence

Opioid dependence is a chronic and relapsing condition characterized by compulsive opioid use despite harmful consequences. Even after successful detoxification, individuals with opioid use disorder (OUD) remain at high risk for relapse, particularly during the early stages of recovery. Effective relapse prevention is therefore essential to achieving long-term abstinence and improved quality of life. The